DCW
24.10.2022 08:01:45 CEST | Business Wire | Press release
Digital Construction Works (DCW), a leading construction software integrations and solutions company, announces the availability of JDLink Connectivity, a John Deere wireless connectivity solution in its DCW Integrations Platform as a service (iPaaS) Marketplace.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221024005073/en/
DCW Integrations Platform Marketplace (Graphic: Business Wire)
The JDLink integration enables telematics data from John Deere-connected machines to aggregate into the DCW Integrations Platform for use within automated workflows, dashboards, and reports. Combined with other integrated data sources, like machine control and scheduling systems, integration provides deeper insight into site activities allowing optimization of projects, machine, and operator performance.
“Having the ability to integrate JDLink with other products used in construction projects is a big step forward in advancing digital capability. We are truly enabling the connection of the job site to the office,” said Jason Hallett, CEO of Digital Construction Works. Hallett also said: “Automation and availability of integrated data provide greater insights into the overall project performance and status. This consolidated view allows customers like RDO, for example, to have complete visibility into all of their construction equipment and vehicles. As a result, these organizations can maximize efficiency and uptime and improve communication workflows.”
“With the ability to integrate JDLink with other construction project technology, we can connect multiple solutions removing the need for double entry of information. The integration enables analytics derived from aggregated data not previously possible without the DCW Integrations Platform,” said Adam Gilbertson, Vice President at RDO Equipment Co., a large international John Deere dealer network. “We are excited about what this connection will mean for contractors trying to make decisions that improve efficiency on the job.”
FEATURES:
- Get machine location and performance data from JDLink
- Get organizational and fleet information from JDLink
- Access information anywhere, anytime
BENEFITS
- Visualize data points like fuel consumption and idle time on a central dashboard
- Gain deeper insight into machine performance through a combination of JDLink data points with task information and information from machine control systems
- Learn about operator behavior through a combination of JDLink data points with machine control systems
- Detailed insight into fuel consumption and CO2 emissions related to on-site activities by combining JDLink data with machine control systems
- Run day-to-day operations with ease
Digital Construction Works (DCW) will be in the Topcon Positioning Systems stand, Hall A2, Stand 249, at the Bauma World Trade Fair, October 24 – 30th in Munich, Germany, Trade Fair Center Messe München. The company will feature its Integrations Platform, Construction Progress Tracking Solution, and its Construction Monitoring Services, Products, and Integrated Solutions, which combine Topcon sensors with Infrastructure IoT sensors. DCW is a Topcon Positioning Systems and Bentley Systems joint venture company.
Bauma is the World's Leading Trade Fair for Construction Machinery, Building Material Machines, Mining Machines, Construction Vehicles, and Construction Equipment
About Digital Construction Works, Inc. (DCW):
Digital Construction Works (DCW) is an integrations services and solution company. DCW manages the burden and reduces the debt associated with integrating the technology ecosystem, delivering value through workflow automation and application expertise that considers current and planned technology investments. The DCW Integrations Platform orchestrates the connected data sources and workflows to generate project insights that help operate more efficiently and profitably. DCW also provides Construction Monitoring Services, Products, and Integrated Solutions, which combine Topcon sensors with infrastructure IoT sensors. www.digitalconstructionworks.com
Logos and brands mentioned by name herein are registered or non-registered trademarks of their respective owner.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221024005073/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom